Effects of acute and chronic administration of phencyclidine on the A10 dopaminergic mesolimbic system: Electrophysiological and behavioral correlates

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Electrophysiological and behavioral methods were used to evaluate the effects of chronic exposure to phencyclidine (PCP, 5 mg/kg/day for 30 days) on ventral tegmental A10 dopaminergic neurons and locomotor and ataxic behavior in the rat. Extracellular recordings from single neurons in the ventral tegmentum showed only minimal differences between rats chronically treated with either saline or PCP. A comparison of the rising portion of the cumulative dose-response curves indicated that the animals treated chronically with the drug required only 0.4 times more PCP than the controls to produce equivalent changes in neuronal firing rates. Also, the average maximum increase in activity in A10 neurons, induced by PCP, was 43% in the drug-treated rats compared to 60% in the controls. Although these were moderate quantitative changes, a marked qualitative difference in the response of A10 neurons to PCP was seen. Whereas PCP elicited a characteristic dose-dependent biphasic effect on the firing rates in the control group, the declining (inhibitory) component of the response was not present in the animals chronically treated with PCP. In parallel with the minimal electfophysiological changes, measurements of gross locomotor activity showed that the response to the thirtieth (30th) injection of PCP was virtually identical to that measured in the same animals following the first exposure. In contrast, however, the ataxia which accompanied the hyperactivity rapidly diminished over the course of treatment. It would appear, therefore, that chronic exposure to PCP did not substantially diminish the ability of PCP to activate the A10 neurons, comprising the mesocorticolimbic dopaminergic systems. In fact, with long-term chronic use of PCP, larger doses may actually result in a greater degree of stimulation of midbrain dopaminergic neurons. This effect may partially underly the neurobiological mechanism by which chronic abuse of PCP can eventually lead to psychotic-like personality changes.

Original languageEnglish (US)
Pages (from-to)791-798
Number of pages8
JournalNeuropharmacology
Volume27
Issue number8
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Phencyclidine
antineoplaston A10
Neurons
Dopaminergic Neurons
Phencyclidine Abuse
Aptitude
Ataxia
Locomotion
Mesencephalon
Pharmaceutical Preparations
Personality
Control Groups
Injections
Therapeutics

Keywords

  • ataxia
  • dopamine neurons
  • electrophysiology
  • locomotor activity
  • phencyclidine
  • tolerance

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

@article{c63ca06d852d41fa97a0bc3c2fdb55eb,
title = "Effects of acute and chronic administration of phencyclidine on the A10 dopaminergic mesolimbic system: Electrophysiological and behavioral correlates",
abstract = "Electrophysiological and behavioral methods were used to evaluate the effects of chronic exposure to phencyclidine (PCP, 5 mg/kg/day for 30 days) on ventral tegmental A10 dopaminergic neurons and locomotor and ataxic behavior in the rat. Extracellular recordings from single neurons in the ventral tegmentum showed only minimal differences between rats chronically treated with either saline or PCP. A comparison of the rising portion of the cumulative dose-response curves indicated that the animals treated chronically with the drug required only 0.4 times more PCP than the controls to produce equivalent changes in neuronal firing rates. Also, the average maximum increase in activity in A10 neurons, induced by PCP, was 43{\%} in the drug-treated rats compared to 60{\%} in the controls. Although these were moderate quantitative changes, a marked qualitative difference in the response of A10 neurons to PCP was seen. Whereas PCP elicited a characteristic dose-dependent biphasic effect on the firing rates in the control group, the declining (inhibitory) component of the response was not present in the animals chronically treated with PCP. In parallel with the minimal electfophysiological changes, measurements of gross locomotor activity showed that the response to the thirtieth (30th) injection of PCP was virtually identical to that measured in the same animals following the first exposure. In contrast, however, the ataxia which accompanied the hyperactivity rapidly diminished over the course of treatment. It would appear, therefore, that chronic exposure to PCP did not substantially diminish the ability of PCP to activate the A10 neurons, comprising the mesocorticolimbic dopaminergic systems. In fact, with long-term chronic use of PCP, larger doses may actually result in a greater degree of stimulation of midbrain dopaminergic neurons. This effect may partially underly the neurobiological mechanism by which chronic abuse of PCP can eventually lead to psychotic-like personality changes.",
keywords = "ataxia, dopamine neurons, electrophysiology, locomotor activity, phencyclidine, tolerance",
author = "French, {Edward D}",
year = "1988",
doi = "10.1016/0028-3908(88)90093-7",
language = "English (US)",
volume = "27",
pages = "791--798",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Effects of acute and chronic administration of phencyclidine on the A10 dopaminergic mesolimbic system

T2 - Electrophysiological and behavioral correlates

AU - French, Edward D

PY - 1988

Y1 - 1988

N2 - Electrophysiological and behavioral methods were used to evaluate the effects of chronic exposure to phencyclidine (PCP, 5 mg/kg/day for 30 days) on ventral tegmental A10 dopaminergic neurons and locomotor and ataxic behavior in the rat. Extracellular recordings from single neurons in the ventral tegmentum showed only minimal differences between rats chronically treated with either saline or PCP. A comparison of the rising portion of the cumulative dose-response curves indicated that the animals treated chronically with the drug required only 0.4 times more PCP than the controls to produce equivalent changes in neuronal firing rates. Also, the average maximum increase in activity in A10 neurons, induced by PCP, was 43% in the drug-treated rats compared to 60% in the controls. Although these were moderate quantitative changes, a marked qualitative difference in the response of A10 neurons to PCP was seen. Whereas PCP elicited a characteristic dose-dependent biphasic effect on the firing rates in the control group, the declining (inhibitory) component of the response was not present in the animals chronically treated with PCP. In parallel with the minimal electfophysiological changes, measurements of gross locomotor activity showed that the response to the thirtieth (30th) injection of PCP was virtually identical to that measured in the same animals following the first exposure. In contrast, however, the ataxia which accompanied the hyperactivity rapidly diminished over the course of treatment. It would appear, therefore, that chronic exposure to PCP did not substantially diminish the ability of PCP to activate the A10 neurons, comprising the mesocorticolimbic dopaminergic systems. In fact, with long-term chronic use of PCP, larger doses may actually result in a greater degree of stimulation of midbrain dopaminergic neurons. This effect may partially underly the neurobiological mechanism by which chronic abuse of PCP can eventually lead to psychotic-like personality changes.

AB - Electrophysiological and behavioral methods were used to evaluate the effects of chronic exposure to phencyclidine (PCP, 5 mg/kg/day for 30 days) on ventral tegmental A10 dopaminergic neurons and locomotor and ataxic behavior in the rat. Extracellular recordings from single neurons in the ventral tegmentum showed only minimal differences between rats chronically treated with either saline or PCP. A comparison of the rising portion of the cumulative dose-response curves indicated that the animals treated chronically with the drug required only 0.4 times more PCP than the controls to produce equivalent changes in neuronal firing rates. Also, the average maximum increase in activity in A10 neurons, induced by PCP, was 43% in the drug-treated rats compared to 60% in the controls. Although these were moderate quantitative changes, a marked qualitative difference in the response of A10 neurons to PCP was seen. Whereas PCP elicited a characteristic dose-dependent biphasic effect on the firing rates in the control group, the declining (inhibitory) component of the response was not present in the animals chronically treated with PCP. In parallel with the minimal electfophysiological changes, measurements of gross locomotor activity showed that the response to the thirtieth (30th) injection of PCP was virtually identical to that measured in the same animals following the first exposure. In contrast, however, the ataxia which accompanied the hyperactivity rapidly diminished over the course of treatment. It would appear, therefore, that chronic exposure to PCP did not substantially diminish the ability of PCP to activate the A10 neurons, comprising the mesocorticolimbic dopaminergic systems. In fact, with long-term chronic use of PCP, larger doses may actually result in a greater degree of stimulation of midbrain dopaminergic neurons. This effect may partially underly the neurobiological mechanism by which chronic abuse of PCP can eventually lead to psychotic-like personality changes.

KW - ataxia

KW - dopamine neurons

KW - electrophysiology

KW - locomotor activity

KW - phencyclidine

KW - tolerance

UR - http://www.scopus.com/inward/record.url?scp=0023695070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023695070&partnerID=8YFLogxK

U2 - 10.1016/0028-3908(88)90093-7

DO - 10.1016/0028-3908(88)90093-7

M3 - Article

C2 - 3216958

AN - SCOPUS:0023695070

VL - 27

SP - 791

EP - 798

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 8

ER -